Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 194,586 shares at $27.47 ($5.3M) on 2022-12-02, disclosed to the SEC on 2022-12-06.
Open-market sale of $5.3M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.47 | 88,462 | $2.4M | 45.5% |
| 2 | $27.47 | 88,462 | $2.4M | 45.5% |
| 3 | $27.25 | 8,831 | $241K | 4.5% |
| 4 | $27.25 | 8,831 | $241K | 4.5% |
| Total | $27.45 avg | 194,586 | $5.3M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |